Women's Health Vitals for February 2017

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

We screened more than 1538 studies on Women's Health this month. These are the most important.

ACOG Committee Opinion: strategies for limiting labor interventions

Source: Obstet Gynecol

  • Patient-centered care involves the input of the patient; many patients seek to reduce medical interventions during labor and delivery.
  • ACOG supports the trend of patient-centered care; this may represent a paradigm shift for some obstetric care providers.
  • There are limited studies on many basic and common obstetrics practices; continuing research and review is needed.


 More details »


Risk for pregnancy low with any cycle day start of subdermal contraceptive implants

Source: Contraception

  • Traditionally, hormonal contraception has been started with the menstrual period to ensure effectiveness and lack of pregnancy. However, adolescents face barriers to returning for contraception; same-day insertion is safe and effective and can increase compliance.
  • Long-acting reversible contraception (LARC) should be the first-line recommendation for all women and adolescents.
  • LARC is partially responsible for declining adolescent pregnancy rates in the United States.


 More details »  

SMFM: acetaminophen use during pregnancy is safe

Source: Am J Obstet Gynecol

  • Acetaminophen (APAP) is the most widely used medication during pregnancy.
  • Women are counseled that the use of acetaminophen during pregnancy is safe.
  • The Society for Maternal-Fetal Medicine's opinion is that these recommendations should not be changed, but the risks and benefits of medications always need to be discussed.


  More details »


Previous Vitals on Women's Health:  January '17

Other recent Vitals: